Ashley C. Gucinski
United States Food and Drug Administration(US)Center for Drug Evaluation and Research(US)
Publications by Year
Research Areas
Mass Spectrometry Techniques and Applications, Advanced Proteomics Techniques and Applications, Analytical Chemistry and Chromatography, Protein purification and stability, Metabolomics and Mass Spectrometry Studies
Most-Cited Works
- → Evidence of Diketopiperazine and Oxazolone Structures for HA b2+ Ion(2009)96 cited
- → Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry(2013)52 cited
- → Evaluation of Intact Mass Spectrometry for the Quantitative Analysis of Protein Therapeutics(2012)39 cited
- → Structural Influences on Preferential Oxazolone versus Diketopiperazine b2+ Ion Formation for Histidine Analogue-Containing Peptides(2012)37 cited
- → Separation and identification of structural isomers by quadrupole collision-induced dissociation-hydrogen/deuterium exchange-infrared multiphoton dissociation (QCID-HDX-IRMPD)(2010)31 cited
- → Influence of N-terminal Residue Composition on the Structure of Proline-Containing b2+ Ions(2013)28 cited
- → Identification of site‐specific heterogeneity in peptide drugs using intact mass spectrometry with electron transfer dissociation(2014)27 cited
- → Analytical techniques and bioactivity assays to compare the structure and function of filgrastim (granulocyte-colony stimulating factor) therapeutics from different manufacturers(2013)26 cited
- → Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control(2015)25 cited
- → Modern analytics for naturally derived complex drug substances: NMR and MS tests for protamine sulfate from chum salmon(2014)19 cited